Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported Q3 EPS of ($0.06), $0.04 better than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.